Novotech White Papers

  1. Opportunities For Ophthalmology Clinical Development In APAC: Glaucoma 1/6/2023

    The world is heavily burdened by glaucoma, which is the second-leading cause of blindness and the primary cause of irreversible blindness. Learn about its effects in the Asia Pacific.

  2. Peanut Allergy: Asia Pacific Clinical Trial Landscape 1/6/2023

    Explore the differences between the common food allergies in Asia and the West, specifically the peanut allergy.

  3. Paroxysmal Nocturnal HemoglobinuriaIn: The Asia Pacific Clinical Trial Landscape 1/6/2023

    Paroxysmal nocturnal hemoglobinuria (PNH) is a rare condition that affects the ability of hematopoietic stem cells and their cellular offspring to bind specific proteins to the cell surface.

  4. Top Therapeutic Areas In The Asia Pacific Clinical Trial Landscape 1/6/2023

    Explore why the Asia-Pacific region has emerged as a clinical trial hub due to the ease of regulatory compliance, low trial costs, rising patient population, and the availability of top clinical institutions as trial locations

  5. Cell & Gene Therapy In The Asia Pacific Clinical Trial Landscape 1/6/2023

    Discover how a new class of therapeutics called cell and gene therapies are revolutionizing how diseases are treated and even potentially cured.

  6. The Biotech Landscape: Opportunities In China And The Path To USFDA Approval 11/7/2022

    In this white paper, learn why western biopharma companies should take advantage of China’s revamped regulatory framework.

  7. Next Generation Sequencing In The Asia Pacific: The Availability & Reimbursement Landscape 9/22/2022

    Next generation sequencing (NGS) refers to a technology that detects genomic variation that is present at birth or emerges later in life. This report describes the availability of NGS in a selection of locations.

  8. How Biotechs Are Using DCT Technology To Conduct Trials In The APAC Region 9/22/2022

    In this white paper, gain insight into how the Asia Pacific region, with its rapid growth of clinical trials, presents a great opportunity for conducting clinical research and has become the preferred destination for DCTs.

  9. The Immuno-Oncology Clinical Trial Landscape In The Asia Pacific 9/22/2022

    Learn how the Asia Pacific has shown significant increase in Immuno-oncology (IO) trials between 2017 and 2021 and contributes to about 35% of clinical development in IO globally. 

  10. Clinical Development Strategies For Western Biotech Companies In China 9/22/2022

    Delve into how China is now more aligned with international standards, enabling biotech firms to streamline processes and timelines, which has significantly recharged biotech innovation.